U.S. veterans who were exposed to Agent Orange have a modestly increased risk of bladder cancer, according to a recent study, which also found that younger Vietnam veterans appeared to be in the most peril.
No Increased Bladder Cancer Risk Seen With SGLT2 Inhibitors
For years, reports of higher risks of breast and bladder cancer with the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors have raised concerns.
Microscopic Hematuria in Urine Rarely Raises Cancer Risk
The discovery of blood in the urine might be alarming, but do patients with microscopic hematuria (MH) and a negative initial evaluation have an elevated risk for urinary carcinoma?
Recurrence Risk Lower When Blue Light Cystoscopy Used for Detection
White light cystoscopy has been found less effective in detecting cases of nonmuscle-invasive bladder cancer (NMIBC) than blue light cystoscopy.
Arkansas VAMC Illuminates Bladder Cancer Using Blue Light Cystoscopy
Early-stage cancers can be very challenging to see, but finding them before they advance provides the best chance for curative treatment with the fewest complications.
Using Chemotherapy After Noninvasive Bladder Cancer
Using one dose of intravesical chemotherapy immediately following surgery for nonmuscle invasive bladder cancer is recommended in national and international guidelines.
Diagnosis of Bladder Cancer Has Dropped During COVID-19 Pandemic
In 2020, compared with baseline years 2018 through 2019, more than 2,000 fewer bladder cancers were diagnosed in the VA’s healthcare system.
Extracting VA Data on Invasive Bladder Cancer
Bladder cancer is the VA’s fourth-most-diagnosed cancer, and early diagnosis is important because, if the tumor spreads outside the bladder, the five-year survival rate is only about 38%.